Skip to main content

Table 3 Results of stepwise logistic regression analyses of preoperative variables associated with an vision gainer (improvement in the BCVA >0 LogMAR units from the baseline) at 12 months after the initial IVR

From: Effectiveness of intravitreal ranibizumab in exudative age-related macular degeneration (AMD): comparison between typical neovascular AMD and polypoidal choroidal vasculopathy over a 1 year follow-up

Variable

OR

95% CI

P value

BMI

1.3

1.0 - 1.6

0.031

Phenotype (PCV = 0, tAMD =1)

4.3

1.2 - 15.9

0.029

  1. OR, Odds ratio; CI, Confidence interval; BMI, Body mass index.
  2. The number of vision gainer and non-gainer was 34 and 20.